Who founded Spotlight Pathology?

Spotlight Pathology was founded by Martin, Richard.

Who are Spotlight Pathology's investors?

Spotlight Pathology's investors include Deepbridge Capital, UK Innovation & Science Seed Fund, Future Planet Capital, River Capital.

Spotlight Pathology

11 known investors

Find your way into Spotlight Pathology

383 people in our graph share verified history with the Spotlight Pathology team — schools, employers, funds. One of them is your warm intro.

Joseph Stolermanunlockedknows Sam Perona (Westgate) · together at University of Leeds

×7knows the team · via University of Leeds

knows the team · via The Manchester Metropolitan University

×2knows the team · via University of Liverpool

knows the team · via Prifysgol Aberystwyth University

Spotlight Pathology develops AI-based diagnostic tools for pathology, particularly focused on blood cancer diagnosis and digital pathology services. The company serves diagnostic laboratories and healthcare centers by providing decision support systems underpinned by machine learning algorithms for image analysis.

AI & Machine Learning Digital Health Healthtech Medical Devices

Founders & leadership

MartinCo-Founder and Chief Technology Officer

RichardCo-Founder and Chief Medical Officer

Sam Perona (Westgate)inChief Executive OfficerSam Perona is Chief Executive Officer of Spotlight Pathology, an AI diagnostics company for pathology. He holds a PhD and MSc, and has commercial research experience including FDA 510(k) submissions and medical device regulatory compliance, along with completion of Goldman Sachs' 10,000 Small Businesses program.

Investors · 11

Deepbridge CapitalChester

UK Innovation & Science Seed FundLondon · $127K – $635K

Future Planet CapitalreportedLondon

River Capitalreported · 2 sourcesLiverpool · $32K – $2.6M

Also in the syndicate · 7

AXM Venture CapitalDeepbridgeEHE VenturesLiverpool City Region Seed FundleadLyva LabsUK Innovation and Science Seed FundleadUKI2Slead

Funding

SEC filings, press & company announcements

Undisclosed amountseed fundingMar 2026
Liverpool City Region Seed Fund (lead), UK Innovation and Science Seed Fund (lead), AXM Venture Capital, Deepbridge, EHE Ventures, Future Planet Capital, Lyva Labs, River Capital
Source ↗

Source: company announcements and press reports — follow each round's link for the claim.

Companies House · registry record

View on Companies House ↗

Registered name: SPOTLIGHT PATHOLOGY LTD
Company number: 12435884
Status: Active
Company type: Private limited company
Incorporated: 31 Jan 2020
Registered office: The Innovation Centre, Sci-Tech Daresbury Keckwick Lane, Daresbury, Warrington, Cheshire, WA4 4FS
Nature of business (SIC): 62012 — Business and domestic software development
Accounts: last made up to 31 Jan 2025 · next due 31 Oct 2026
Confirmation statement: last made up to 30 Jan 2026 · next due 13 Feb 2027

Current officers · 5

Richard John Byers — director, appointed 13 Oct 2021
Martin Paul Fergie — director, appointed 31 Jan 2020
Marcel Gehrung — director, appointed 30 Jan 2026
Samantha Jane Perona — director, appointed 30 Jan 2026
Andrew Edward Round — director, appointed 30 Jan 2026

Source: Companies House public register · retrieved 16 Aug 2026. Contains public sector information licensed under the Open Government Licence v3.0.

In the news

Spotlight Pathology secures new funding for AI cancer diagnostics - UKTNuktech.news · Mar 2026

Sci‑Tech Daresbury firm Spotlight Pathology raises £1.4m for AI cancer diagnostics | Sci-Tech Daresburysci-techdaresbury.com · Mar 2026

Spotlight Pathology raises GBP £1.4m for AI cancer toolitbrief.co.uk · Mar 2026

Liverpool City Region Seed Fund backs Spotlight Pathology’s AI blood cancer diagnostics | Growth Platformgrowthplatform.org · Mar 2026

Spotlight Pathology secures £425k Investment led by EHE Ventures | Medilinkmedilink.co.uk · May 2025

Spotlight Pathology Raises 1.9M USD in Seed Funding | Seedtableseedtable.com

Frequently asked questions

What does Spotlight Pathology do?: Spotlight Pathology develops AI-based diagnostic tools for pathology, particularly focused on blood cancer diagnosis and digital pathology services. The company serves diagnostic laboratories and healthcare centers by providing decision support systems underpinned by machine learning algorithms for image analysis.
Who founded Spotlight Pathology?: Spotlight Pathology was founded by Martin, Richard.
Who are Spotlight Pathology's investors?: Spotlight Pathology's investors include Deepbridge Capital, UK Innovation & Science Seed Fund, Future Planet Capital, River Capital.